Advances in click-enabled dendrimers: bridging molecular engineering, biomedical applications, and clinical translation
Advanced Drug Delivery Reviews · 2026-11 · 115997
DOI: 10.1016/j.addr.2026.115997 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-11. Verfasst von Anubhav Dhull und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 1007 E. Huron St., Ann Arbor, MI 48104, USA; Department of Chemis…. Die Arbeit nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Eye Institute, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Dendrimers are highly branched, multivalent macromolecules with generation-dependent architectures that can be prepared with comparatively well-defined molecular compositions. Their architecture and synthetic tunability enable controlled incorporation of targeting ligands, therapeutic agents, imaging probes, and stimuli-responsive functionalities within a single nanoscale construct. These attributes distinguish dendrimers from many conventional nanocarriers and support their investigation as multifunctional platforms for advanced therapeutic applications. However, broader translation of dendrimer technologies has been hindered by challenges associated with synthetic complexity, manufacturing costs, purification and characterization requirements, large-scale reproducibility, predictable biological performance, and increasingly stringent regulatory expectations for advanced nanomedicines. Click chemistry provides one strategy for addressing some of these synthetic and functionalization limitations by enabling expedited and orthogonal dendrimer construction and further modification. Copper-catalyzed azide-alkyne cycloaddition (CuAAC), strain-promoted azide-alkyne cycloaddition (SPAAC), inverse electron-demand Diels-Alder (IEDDA), thiol-ene, thiol-yne, and related bioorthogonal reactions have expanded the ways in which dendrimers can be synthesized and drugs, targeting ligands, imaging agents, nucleic acids, peptides, proteins, and stimuli-responsive linkers can be incorporated into these scaffolds with greater structural control. This review examines click-enabled dendrimers for various biomedical applications. Emphasis is placed on how dendrimer generation, surface charge, ligand density, linker chemistry, degradability, and click reaction choice influence biological performance and translational potential. Marketed and clinically evaluated dendrimer technologies are also discussed to highlight the design, manufacturing, and characterization requirements needed for broader clinical adoption.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 1007 E. Huron St., Ann Arbor, MI 48104, USA; Department of Chemistry, College of Arts and Sciences, Washington State University, Pullma…
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 1007 E. Huron St., Ann Arbor, MI 48104, USA.
Förderung
- National Eye Institute
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Dhull, A., Gopalakrishnan, S., Pulukuri, A. J., Rani, A., Jain, V., Sharma, R., & Sharma, A. (2026). Advances in click-enabled dendrimers: bridging molecular engineering, biomedical applications, and clinical translation. Advanced Drug Delivery Reviews, 115997. https://doi.org/10.1016/j.addr.2026.115997
Vancouver
Dhull A, Gopalakrishnan S, Pulukuri AJ, Rani A, Jain V, Sharma R, et al. Advances in click-enabled dendrimers: bridging molecular engineering, biomedical applications, and clinical translation. Advanced Drug Delivery Reviews. 2026:115997. doi:10.1016/j.addr.2026.115997
BibTeX
@article{Dhull2026,
author = {Dhull, Anubhav and Gopalakrishnan, Shamila and Pulukuri, Anunay James and Rani, Anu and Jain, Vikrantvir and Sharma, Rishi and Sharma, Anjali},
title = {Advances in click-enabled dendrimers: bridging molecular engineering, biomedical applications, and clinical translation},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
pages = {115997},
doi = {10.1016/j.addr.2026.115997}
}
EUVIMED